|
|
Volumn 132, Issue 2, 1996, Pages 215-219
|
|
Psoriatic arthritis: New types, new treatments
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIMALARIAL AGENT;
ANTIPSORIASIS AGENT;
ANTIRHEUMATIC AGENT;
CYCLOSPORIN;
GLUCOCORTICOID;
GOLD;
IMMUNOSUPPRESSIVE AGENT;
LEUKOTRIENE RECEPTOR BLOCKING AGENT;
METHOTREXATE;
NITRIC OXIDE;
NITRIC OXIDE SYNTHASE INHIBITOR;
NONSTEROID ANTIINFLAMMATORY AGENT;
PHOSPHOLIPASE INHIBITOR;
PSORALEN;
RETINOID;
STEROID;
TACROLIMUS;
ARTHRITIS;
ATOPIC DERMATITIS;
CLINICAL FEATURE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DISEASE CLASSIFICATION;
DRUG CHOICE;
HUMAN;
NAIL DISEASE;
ORAL DRUG ADMINISTRATION;
OSTEOARTHRITIS;
PATHOGENESIS;
PERIOSTITIS;
PRIORITY JOURNAL;
PROGNOSIS;
PSORIASIS;
PSORIATIC ARTHRITIS;
PUSTULOSIS PALMOPLANTARIS;
PUVA;
REVIEW;
TOPICAL DRUG ADMINISTRATION;
ARTHRITIS, PSORIATIC;
DRUG THERAPY, COMBINATION;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
|
|
EID: 0030062412
PISSN: 0003987X
EISSN: None
Source Type: Journal
DOI: 10.1001/archderm.132.2.215 Document Type: Review |
|
Times cited : (33)
|
|
References (0)
|
